ArticleBMC cancer2010

Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment--case report.

Chen-Hsi Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.